Spondyloarthritis (SpA) is a family of chronic inflammatory diseases, being the most
prevalent ankylosing spondylitis (AS) and psoriatic arthritis (PsA). These diseases share …

Pharmaceutics | Free Full-Text | Mesenchymal Stem Cell-Derived Extracellular Vesicles as
Non-Coding RNA Therapeutic Vehicles in Autoimmune Diseases Next Article in Journal …

Rheumatoid arthritis (RA) is an autoimmune chronic inflammatory disease that is still not
well understood in terms of its pathogenesis and presents diagnostic and therapeutic …

Introduction A number of studies have demonstrated a key role of miRNA isolated from cells,
tissue or body fluids as disease-specific biomarkers of autoimmune rheumatic diseases …

Introduction Monocytes are key effector cells in inflammatory processes. We and others have
previously shown that synovial monocytes in childhood-onset arthritis are activated …

Baricitinib is a Janus kinase (JAK) 1 and 2 inhibitor approved for treating rheumatoid arthritis
(RA). The JAK/STAT system is essential in the intracellular signaling of different cytokines …

Rheumatoid arthritis (RA) is one of the most common autoimmune diseases worldwide,
causing severe cartilage damage and disability. Despite the recent progress made in RA …

It is well documented that patients affected by rheumatoid arthritis (RA) have distinct
susceptibility to the different biologic DMARDs available on the market, probably because of …

Background α-Mangostin (MG) showed the potentials in alleviating experimental arthritis,
inhibiting inflammatory polarization of macrophages/monocytes, and regulating peroxisome …

Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by synovial
inflammation, cartilage destruction, pannus formation and bone erosion. Various immune …